Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation

Keyphrases

• Anticoagulants 100%
• Atrial Fibrillation 100%
• Advancing Age 100%
• Bleeding Risk 100%
• Strong Barrier 100%
• Anticoagulation 66%
• Bleeding 66%
• Fall Risk 66%
• Aging 33%
• Survey Questionnaire 33%
• Clinical Practice 33%
• Cognitive Impairment 33%
• Comorbidity 33%
• Alcohol 33%
• Increasing Age 33%
• Advanced Age 33%
• International Normalized Ratio 33%
• Stroke Risk 33%
• Warfarin 33%
• Anticoagulant Therapy 33%
• Clinical Interview 33%
• Lack of Compliance 33%
• Mead 33%
• Narrow Therapeutic Window 33%
• Thromboembolic Risk 33%
• Clinical Vignette 33%
• Anticoagulant Treatment 33%
• Oral Anticoagulation 33%
• Physician Attitudes 33%
• Concomitant Medications 33%
• Chronic Alcoholism 33%
• Comorbities 33%

Medicine and Dentistry

• Antithrombotic 100%
• Bleeding 100%
• Anticoagulation 100%
• Atrial Fibrillation 100%
• Anticoagulant Therapy 66%
• Cognitive Defect 33%
• Comorbidity 33%
• Apoplexy 33%
• Systematic Review 33%
• Alcoholic Polyneuropathy 33%
• Therapeutic Window 33%
• Warfarin 33%
• Physician Attitude 33%
• Thromboembolism 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Bleeding 100%
• Atrial Fibrillation 100%
• Comorbidity 25%
• Cognitive Defect 25%
• Warfarin 25%
• Cerebrovascular Accident 25%
• Ethanol 25%
• Thromboembolism 25%
• Therapeutic Window 25%